DASATINIB Zentiva cpr pell 50 mg 60 pce
7680682560028
CH-68256
L01EA02
07.16.1.
Reimbursement limitations:
SPRYCEL2
Ce dosage est exclu pour le traitement de patients souffrant de leucémie myéloïde chronique à …
1 / 3
google
Details
- Product number
- 6825602
- CPT
- -
- Packaging group
- 60
- Unit
- Tablette(n)
- Composition
- dasatinibum 50 mg, lactosum monohydricum 67.5 mg, cellulosum microcristallinum, hydroxypropylcellulosum, carmellosum natricum conexum corresp. natrium 0.36 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 1.68 mg, E 171, triacetinum, pro compresso obducto.
Articles (1)
Dasatinib Zentiva 50 mg, Filmtabletten
Filmtabletten
60
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
67.5 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.36 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
1.68 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 1183.10
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/12/2022
Authorization holder
Helvepharm AG
8500 Frauenfeld
Authorization information
- Swissmedic authorization number
- 68256
- Drug name
- Dasatinib Zentiva, Filmtabletten
- Galenic form
- FILM
- ATC Code
- L01EA02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 10/06/2021
- Authorization expiration date
- 09/06/2026
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- DASATINIB Zentiva cpr pell 50 mg 60 pce
- Description (DE)
- DASATINIB Zentiva Filmtabl 50 mg 60 Stk
- Market launch
- 10/06/2021
- Narcotic (BTM)
- No